Live feed
Filing
SC 13D/A
SC 13D/A0001571049-18-000074·CELGENE CORP /DE/
Schedule 13D ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,109,160
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001571049-18-000074
- Form type
- SC 13D/A
- Filer
- CELGENE CORP /DE/
- CIK
- CIK 816284
- Filed
- Feb 02, 2018
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership